Duration: (5:25) ?Subscribe5835 2025-02-11T20:10:22+00:00
Imugene expands CAR T-Cell and Oncolytic Virotherapy trials in Australia and the US
(5:25)
Imugene’s $20 million boost and cancer trial updates
(7:42)
Imugene Limited (ASX:IMU) Three Complete Responses in Azer-Cel Phase 1b Trial
(3:51)
Imugene opens enrolment for Bile Tract Cancer expansion study
(5:2)
Imugene Science Series With Dr Yuman Fong - November 2024
(20:20)
Groundbreaking cancer trial: Imugene’s CF33 advances in clinical success
(16:2)
Imugene Investor Presentation | Non-deal Roadshow 2023 Australia
(44:28)
Imugene (ASX: IMU) – The ‘Holy Grail’ Of Cancer Treatment…?! | ASX CEO Interview 🚀📈
(20:37)
Jervois Global (JRV) - Capital Raise Timing \u0026 Amount Explained
(32:44)
Imugene Investor Webinar: MAST Study Update
(27:13)
Imugene MD Talks JustStocks Through Bile Tract Cancer Expansion Study And New Strategic Partnership
(6:20)
Imugene MAST trial delivers two-year complete response in bile tract cancer patient
(4:54)
Affordable Gene Therapies Are Coming! - George Church at EARD
(25:31)
Investor webinar: Azer-cel trial update, September 2024
(25:35)
Imugene has opened enrollment for its expansion study in bile tract cancer patients
(1:5)
Imugene (ASX:IMU) | Webinar with Leslie Chong | 07/11/24
(26:56)
Imugene begins VAXINIA trial for bile tract cancer
(10:)
How Imugene is Turning Viruses into Cancer-Fighting Heroes!
(32:27)
Imugene forges development path of immunotherapies and cancer-killing virus
(24:2)
Imugene Limited R\u0026D Expert Briefing
(1:6:46)
CAR T Explained
(3:58)
Imugene progresses onCARlytics solid tumour trial to combination arm
(3:4)
MD \u0026 CEO Leslie Chong Discusses Bile Tract Cancer Study Expansion \u0026 Strategic Partnership
Biotech Unlocked - IMUGENE ASX:IMU
(18:36)